Clinical trials recruiting for Diffuse Large B Cell Lymphoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cemiplimab | 1 |
| Enzalutamide | 1 |
| Ibrutinib | 1 |
| ONM-501 | 1 |
| Tulmimetostat | 1 |
| ZM008 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 4 |
| Massachusetts | 3 |
| New Jersey | 3 |
| New York | 3 |
| Ohio | 3 |
| Pennsylvania | 3 |
| Virginia | 3 |
| California | 2 |
| Florida | 2 |
| Georgia | 2 |
| Illinois | 2 |
| Michigan | 2 |
Top cities
Self-screener
Recruiting trials
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- A Long-term Extension Study of PCI-32765 (Ibrutinib)
- A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Related conditions
Trials recruiting for Diffuse Large B Cell Lymphoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Diffuse Large B Cell Lymphoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.